We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$1.88B
AUM Growth
+$96.1M
Cap. Flow
+$21.6M
Cap. Flow %
1.15%
Top 10 Hldgs %
23.84%
Holding
447
New
26
Increased
115
Reduced
94
Closed
18

Top Buys

Rank Stock Value
1
FL
Foot Locker
FL
+$31.2M
2
BMY icon
Bristol-Myers Squibb
BMY
+$24.6M
3
AMRN
Amarin Corp
AMRN
+$8.32M
4
BABA icon
Alibaba
BABA
+$7.82M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.41M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$68.8M
2
BIIB icon
Biogen
BIIB
+$9.22M
3
MSFT icon
Microsoft
MSFT
+$8.34M
4
STZ icon
Constellation Brands
STZ
+$8.05M
5
VLO icon
Valero Energy
VLO
+$5.74M

Sector Composition

Rank Sector Weight
1 Healthcare 31.83%
2 Technology 21%
3 Consumer Discretionary 15.41%
4 Financials 9.85%
5 Communication Services 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPZM
126
DELISTED
Epizyme, Inc
EPZM
$3.43M 0.18%
275,200
-33,000
-11% -$425K
NVDA icon
127
NVIDIA
NVDA
$5.12T
$3.42M 0.18%
838,800
+4,800
+0.6% +$19.9K
CHRS icon
128
Coherus Oncology
CHRS
$205M
$3.41M 0.18%
+156,000
New +$2.71M
PTCT icon
129
PTC Therapeutics
PTCT
$5.48B
$3.38M 0.18%
+78,300
New +$3.09M
KYNB
130
Kyntra Bio
KYNB
$31.5M
$3.28M 0.17%
2,948
– –
EEM icon
131
iShares MSCI Emerging Markets ETF
EEM
$30.6B
$3.05M 0.16%
71,100
+15,500
+28% +$658K
JNCE
132
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3M 0.16%
607,687
+39,000
+7% +$207K
REGN icon
133
Regeneron Pharmaceuticals
REGN
$79.7B
$2.95M 0.16%
9,500
-7,850
-45% -$2.61M
DNLI icon
134
Denali Therapeutics
DNLI
$3.26B
$2.94M 0.16%
142,200
+100,000
+237% +$2.24M
RY icon
135
Royal Bank of Canada
RY
$283B
$2.93M 0.16%
37,010
– –
PEGI
136
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$2.85M 0.15%
125,000
+25,000
+25% +$560K
SPWR
137
DELISTED
SunPower Corporation Common Stock
SPWR
$2.85M 0.15%
412,290
– –
IQV icon
138
IQVIA
IQV
$44.4B
$2.84M 0.15%
18,110
-60
-0.3% -$8.42K
OLED icon
139
Universal Display
OLED
$3.58B
$2.82M 0.15%
15,000
– –
LLY icon
140
Eli Lilly
LLY
$1.01T
$2.8M 0.15%
25,100
+2,500
+11% +$294K
RSP icon
141
Invesco S&P 500 Equal Weight ETF
RSP
$98.3B
$2.71M 0.14%
25,100
– –
TECH icon
142
Bio-Techne
TECH
$11.3B
$2.69M 0.14%
52,200
– –
QTTB icon
143
Q32 Bio
QTTB
$333M
$2.69M 0.14%
7,667
+5,556
+263% +$2.18M
CORE
144
DELISTED
Core Mark Holding Co., Inc.
CORE
$2.66M 0.14%
67,000
-103,000
-61% -$3.87M
CTRA
145
DELISTED
Coterra Energy
CTRA
$2.62M 0.14%
114,000
+11,900
+12% +$303K
ITRI icon
146
Itron
ITRI
$4.04B
$2.59M 0.14%
42,000
+14,000
+50% +$778K
XOM icon
147
ExxonMobil
XOM
$696B
$2.58M 0.14%
34,000
– –
AVGO icon
148
Broadcom
AVGO
$1.62T
$2.56M 0.14%
89,550
– –
EMR icon
149
Emerson Electric
EMR
$82B
$2.55M 0.14%
38,250
+1,500
+4% +$100K
HP icon
150
Helmerich & Payne
HP
$4.34B
$2.55M 0.14%
50,400
+6,460
+15% +$356K
4 5
6
7 8

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Erste Asset Management held 447 positions worth $1.88B, up 5.4% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Erste Asset Management's Q2 2019 filing shows 26 new, 115 increased, 94 reduced and 18 closed positions. Its largest new stake was Foot Locker: 600,000 shares worth $25.2M. The largest sale was Celgene Corp, an estimated $68.8M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2019 buy was Foot Locker: 600,000 shares worth $25.2M.
  • Erste Asset Management added most to Bristol-Myers Squibb in Q2 2019, an estimated $24.6M increase.
  • Erste Asset Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $68.8M.
  • Erste Asset Management fully exited Scotiabank in Q2 2019, selling an estimated $1.55M.
  • Erste Asset Management's ten largest holdings make up 24% of its $1.88B portfolio in Q2 2019.
  • Erste Asset Management opened 26 new positions and closed 18 in Q2 2019.
  • Erste Asset Management's portfolio value rose 5.4% quarter-over-quarter to $1.88B.

Based on Erste Asset Management's 13F filing for Q2 2019, filed 22 Nov 2024.